Acute Ischemic Stroke AIS Therapeutics Pipeline Assessment and Market Forecasts to 2018

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

MIV Therapeutics Inc - Strategic SWOT Analysis Review

MIV Therapeutics Inc - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

Summary MIV Therapeutics Inc. (MIVT) is a research and development company that develops biocompatible coatings for stents and other medical devices and advanced drug delivery systems. The company focuses in providing healing solutions for cardiovascular disease and other medical conditions. The company's ...

Industries: Therapy | Countries: Canada, United Kingdom

United Kingdom Compression Therapy Market Outlook to 2020

United Kingdom Compression Therapy Market Outlook to 2020

  • $ 2 500
  • Industry report
  • by Global Data
  • October 2014
  • 67 pages

United Kingdom Compression Therapy Market Outlook to 2020 Summary GlobalData's new report, "United Kingdom Compression Therapy Market Outlook to 2020", provides key market data on the United Kingdom Compression Therapy market. The report provides value, in millions of US dollars, volume (in units) and ...

Industries: Therapy | Countries: United Kingdom

iCo Therapeutics Inc. (ICO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

iCo Therapeutics Inc. (ICO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • July 2014
  • 34 pages

Summary iCo Therapeutics Inc. (iCo) is a development stage pharmaceutical company that develops and commercializes drug candidates for treating ocular and systemic fungal diseases. The product pipeline of the company consists of three compounds, namely, iCo-007, iCo-008 and Oral AmpB Delivery System. ...

Industries: Therapy | Countries: Canada, United Kingdom

The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies

The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies

  • $ 3 013
  • Industry report
  • by Visiongain
  • July 2014
  • 208 pages

Report Details Where is the prostate cancer therapeutics market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 208-page report provides 160 tables, charts, and graphs. Our new study lets you assess leading drugs ...

Industries: Therapy | Countries: United States, World, South Korea, Europe, Brazil, Mexico, Italy, Japan, India, China, United Kingdom, Spain, Russian Federation, France, Germany

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • by GBI Research
  • July 2014
  • 72 pages

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to ...

Industries: Therapy | Countries: France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 60 pages

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 - 40% and is region/climate dependent. For those patients failing to respond to symptomatic treatments ...

Industries: Therapy | Countries: Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • by GBI Research
  • June 2014
  • 112 pages

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business intelligence provider, has released its latest research report, “Glioblastoma Multiforme Therapeutics ...

Industries: Therapy | Countries: World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chiesi Farmaceutici SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 68 pages

Summary Chiesi Farmaceutici SpA (Chiesi) is a research focused pharmaceutical company. The company researches, develops and distributes pharmaceutical products with particular focus on respiratory, cardiovascular, and rare diseases. Its products include Atimos, Bramitob, Clenil, Curosurf, Foster, Iperten, ...

Industries: Therapy | Countries: World, Italy, Europe, United Kingdom, North America, United States, Czech Republic, France

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 3 500
  • Industry report
  • by GBI Research
  • April 2014
  • 122 pages

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma Therapeutics ...

Industries: Therapy | Countries: World, Japan, Canada, Europe, United States, Spain, Italy, France, Germany, United Kingdom, North America

Alliance Pharma Plc (ALR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Alliance Pharma Plc (ALR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • by Global Data
  • February 2014
  • 32 pages

Summary Alliance Pharma plc (Alliance) is a specialty pharmaceutical company. The company focuses acquisition, licensing, registration and marketing of pharmaceutical products. It promotes more than fifty acquired and licensed prescription products across various therapeutic categories. The company has ...

Industries: Therapy | Countries: United Kingdom, Ireland

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.